Please enable JavaScript to continue using this application.

Compare $AVXL vs $KRRO | Chartloom

Compare

$AVXL vs $KRRO

Anavex Life Sciences Corp · Korro Bio Inc

AVXL

Anavex Life Sciences Corp

KRRO

Korro Bio Inc

Compare $AVXL vs $KRRO

Comparing Anavex Life Sciences Corp and Korro Bio Inc

AVXLAnavex Life Sciences Corp

KRROKorro Bio Inc

AVXLAnavex Life Sciences Corp

Market cap

$138M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-59.5%

52W performance

-84.9%

FCF yield

-21.2%

KRROKorro Bio Inc

Market cap

$147M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

143.63x

Rev growth (TTM)

-62.1%

YTD performance

26.2%

52W performance

-77.8%

FCF yield

-46.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AVXL

KRRO

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

KRRO

Korro Bio Inc

Market Cap

AVXL$138M

KRRO$147M

Enterprise Value

AVXL$20M

KRRO$122M

Price

AVXL$1.49

KRRO$10.16

P/E Ratio

AVXLN/A

KRRON/A

P/S Ratio

AVXL0.00x

KRRO61.51x

EV/Sales

AVXL0.00x

KRRO51.05x

EV/EBITDA

AVXL0.00x

KRRO0.00x

P/B Ratio

AVXL1.50x

KRRO1.38x

P/FCF Ratio

AVXLN/A

KRRON/A

EV/FCF

AVXL-0.67x

KRRO-1.78x

PEG Ratio

AVXLN/A

KRRON/A

Forward P/E (NTM)

AVXLN/A

KRRON/A

Forward P/S (NTM)

AVXLN/A

KRRO143.63x

Revenue (TTM)

AVXL$0

KRRO$2M

Revenue Growth (YoY)

AVXLN/A

KRRO-62.1%

Forward Rev Growth

AVXL377.5%

KRRO240.0%

Gross Margin (TTM)

AVXL0.0%

KRRO0.0%

Operating Margin (TTM)

AVXL0.0%

KRRO0.0%

EBITDA Margin (TTM)

AVXL0.0%

KRRO-3068.6%

Net Margin (TTM)

AVXL0.0%

KRRO-4477.1%

FCF Margin (TTM)

AVXLN/A

KRRO-2865.9%

Net Income (TTM)

AVXL$-13M

KRRO$-107M

FCF (TTM)

AVXL$-29M

KRRO$-68M

EPS (TTM)

AVXL-$0.14

KRRO-$6.05

ROE (TTM)

AVXL-1143.0%

KRRO-11426.0%

ROA (TTM)

AVXL-1072.0%

KRRO-6857.0%

ROIC (TTM)

AVXL-1143.0%

KRRO-11426.0%

Cash

AVXL$118M

KRRO$25M

Debt

AVXL$0

KRRO$0

Net Cash/Debt

AVXL$118M

KRRO$25M

Current Ratio (TTM)

AVXL15.62x

KRRO9.55x

Quick Ratio (TTM)

AVXL15.51x

KRRO9.11x

Debt/Equity (TTM)

AVXL0.00x

KRRO0.00x

Debt/Assets (TTM)

AVXL0.0%

KRRO0.0%

Interest Coverage (TTM)

AVXLN/A

KRRON/A

Net Debt/EBITDA (TTM)

AVXL0.00x

KRRO0.00x

Beta

AVXL1.20

KRRO3.27

52W Performance

AVXL-84.9%

KRRO-77.8%

YTD Performance

AVXL-59.5%

KRRO26.2%

% from 52W High

AVXL-85.0%

KRRO-81.8%

% from 52W Low

AVXL3.5%

KRRO95.2%

Asset Turnover (TTM)

AVXL0.00x

KRRO0.04x

FCF Yield (TTM)

AVXL-21.2%

KRRO-46.6%

Earnings Yield (TTM)

AVXL-9.4%

KRRO-72.8%

Dividend Yield (TTM)

AVXLN/A

KRRON/A

Rule of 40

AVXL0.0

KRRO-2,927.9

EV/GP/RG

AVXLN/A

KRRON/A

Ticker research

View AVXL research View KRRO research

Metric	AVXL Anavex Life Sciences Corp	KRRO Korro Bio Inc
Market & Valuation
Market Cap	$138M	$147M
Enterprise Value	$20M	$122M
Price	$1.49	$10.16
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	61.51x
EV/Sales	0.00x	51.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	1.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-1.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	143.63x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-62.1%
Forward Rev Growth	377.5%	240.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3068.6%
Net Margin (TTM)	0.0%	-4477.1%
FCF Margin (TTM)	N/A	-2865.9%
Net Income (TTM)	$-13M	$-107M
FCF (TTM)	$-29M	$-68M
EPS (TTM)	-$0.14	-$6.05
ROE (TTM)	-1143.0%	-11426.0%
ROA (TTM)	-1072.0%	-6857.0%
ROIC (TTM)	-1143.0%	-11426.0%
Financial Health
Cash	$118M	$25M
Debt	$0	$0
Net Cash/Debt	$118M	$25M
Current Ratio (TTM)	15.62x	9.55x
Quick Ratio (TTM)	15.51x	9.11x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	3.27
52W Performance	-84.9%	-77.8%
YTD Performance	-59.5%	26.2%
% from 52W High	-85.0%	-81.8%
% from 52W Low	3.5%	95.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-21.2%	-46.6%
Earnings Yield (TTM)	-9.4%	-72.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,927.9
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View KRRO research

Valuation

P/S Ratio

AVXL

0.00x

KRRO

61.51x

EV/FCF

KRRO

-1.78x

AVXL

-0.67x

Growth & revenue

Revenue Growth TTM

KRRO

-62.1%

Forward Revenue Growth

AVXL

377.5%

KRRO

240.0%

Profitability & performance

Gross Margin

AVXL

0.0%

KRRO

0.0%

ROE

AVXL

-1143.0%

KRRO

-11426.0%

FCF Yield %

AVXL

-21.2%

KRRO

-46.6%

52-Week Performance

KRRO

-77.8%

AVXL

-84.9%

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

KRRO

Korro Bio Inc

Market Cap

AVXL$138M

KRRO$147M

Enterprise Value

AVXL$20M

KRRO$122M

Price

AVXL$1.49

KRRO$10.16

P/E Ratio

AVXLN/A

KRRON/A

P/S Ratio

AVXL0.00x

KRRO61.51x

EV/Sales

AVXL0.00x

KRRO51.05x

EV/EBITDA

AVXL0.00x

KRRO0.00x

P/B Ratio

AVXL1.50x

KRRO1.38x

P/FCF Ratio

AVXLN/A

KRRON/A

EV/FCF

AVXL-0.67x

KRRO-1.78x

PEG Ratio

AVXLN/A

KRRON/A

Forward P/E (NTM)

AVXLN/A

KRRON/A

Forward P/S (NTM)

AVXLN/A

KRRO143.63x

Revenue (TTM)

AVXL$0

KRRO$2M

Revenue Growth (YoY)

AVXLN/A

KRRO-62.1%

Forward Rev Growth

AVXL377.5%

KRRO240.0%

Gross Margin (TTM)

AVXL0.0%

KRRO0.0%

Operating Margin (TTM)

AVXL0.0%

KRRO0.0%

EBITDA Margin (TTM)

AVXL0.0%

KRRO-3068.6%

Net Margin (TTM)

AVXL0.0%

KRRO-4477.1%

FCF Margin (TTM)

AVXLN/A

KRRO-2865.9%

Net Income (TTM)

AVXL$-13M

KRRO$-107M

FCF (TTM)

AVXL$-29M

KRRO$-68M

EPS (TTM)

AVXL-$0.14

KRRO-$6.05

ROE (TTM)

AVXL-1143.0%

KRRO-11426.0%

ROA (TTM)

AVXL-1072.0%

KRRO-6857.0%

ROIC (TTM)

AVXL-1143.0%

KRRO-11426.0%

Cash

AVXL$118M

KRRO$25M

Debt

AVXL$0

KRRO$0

Net Cash/Debt

AVXL$118M

KRRO$25M

Current Ratio (TTM)

AVXL15.62x

KRRO9.55x

Quick Ratio (TTM)

AVXL15.51x

KRRO9.11x

Debt/Equity (TTM)

AVXL0.00x

KRRO0.00x

Debt/Assets (TTM)

AVXL0.0%

KRRO0.0%

Interest Coverage (TTM)

AVXLN/A

KRRON/A

Net Debt/EBITDA (TTM)

AVXL0.00x

KRRO0.00x

Beta

AVXL1.20

KRRO3.27

52W Performance

AVXL-84.9%

KRRO-77.8%

YTD Performance

AVXL-59.5%

KRRO26.2%

% from 52W High

AVXL-85.0%

KRRO-81.8%

% from 52W Low

AVXL3.5%

KRRO95.2%

Asset Turnover (TTM)

AVXL0.00x

KRRO0.04x

FCF Yield (TTM)

AVXL-21.2%

KRRO-46.6%

Earnings Yield (TTM)

AVXL-9.4%

KRRO-72.8%

Dividend Yield (TTM)

AVXLN/A

KRRON/A

Rule of 40

AVXL0.0

KRRO-2,927.9

EV/GP/RG

AVXLN/A

KRRON/A

Ticker research

View AVXL research View KRRO research

Metric	AVXL Anavex Life Sciences Corp	KRRO Korro Bio Inc
Market & Valuation
Market Cap	$138M	$147M
Enterprise Value	$20M	$122M
Price	$1.49	$10.16
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	61.51x
EV/Sales	0.00x	51.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	1.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-1.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	143.63x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-62.1%
Forward Rev Growth	377.5%	240.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3068.6%
Net Margin (TTM)	0.0%	-4477.1%
FCF Margin (TTM)	N/A	-2865.9%
Net Income (TTM)	$-13M	$-107M
FCF (TTM)	$-29M	$-68M
EPS (TTM)	-$0.14	-$6.05
ROE (TTM)	-1143.0%	-11426.0%
ROA (TTM)	-1072.0%	-6857.0%
ROIC (TTM)	-1143.0%	-11426.0%
Financial Health
Cash	$118M	$25M
Debt	$0	$0
Net Cash/Debt	$118M	$25M
Current Ratio (TTM)	15.62x	9.55x
Quick Ratio (TTM)	15.51x	9.11x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	3.27
52W Performance	-84.9%	-77.8%
YTD Performance	-59.5%	26.2%
% from 52W High	-85.0%	-81.8%
% from 52W Low	3.5%	95.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-21.2%	-46.6%
Earnings Yield (TTM)	-9.4%	-72.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,927.9
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View KRRO research